Nlt 95% Powder Levofloxacin Related Compound B, 100986-89-8
Product Details
- Product NameNlt 95% Powder Levofloxacin Related Compound B, 100986-89-8
- CAS No.100986-89-8
- EINECS No.1533716-785-6
- MFC13H9F2NO4
- MW281.21
- AppearanceneatWhite
- Melting point >300 °C (lit.)
- storage temp. Sealed in dry,Room Temperature
- Boiling point 459.2±45.0 °C(Predicted)
- density 1.61±0.1 g/cm3(Predicted)
Pharmacopoeia: USP
Molecular Weight: 281.21
Grade Standard: Analytical Grade
Documents Available: COA,HPLC,MASS,HNMR,CNMR,TGA,IR,SER
Molecular Formula: C13H9F2NO4
Iupac Name: (S)-9,10-Difluro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
Usage/Application: Analytical
Solubility: DMSO
CAS Number: 100986-89-8
Country of Origin: Made in India
Purity: NLT 95%
Form: Powder
Company Profile Introduction
Recommended supplier
-
VIP4年
- GLP Pharma Standards
- Levofloxacin Q acid Impurity NLT 95%
- Inquiry
- 2026-04-02
-
VIP0年
- GLP Pharma Standards
- Levofloxacin Q acid Impurity NLT 95%
- Inquiry
- 2026-04-02
-
VIP4年
- GLP Pharma Standards
- Levofloxacin - Impurity B/ Levofloxacin Related Compound A NLT 95%
- Inquiry
- 2026-04-03
-
VIP0年
- GLP Pharma Standards
- Levofloxacin - Impurity B/ Levofloxacin Related Compound A NLT 95%
- Inquiry
- 2026-04-03
-
VIP4年
- GLP Pharma Standards
- 117707-40-1 Levofloxacin USP Related Compound A/ Levofloxacin EP Impurity B NLT 95%
- Inquiry
- 2026-04-02
-
VIP0年
- GLP Pharma Standards
- 117707-40-1 Levofloxacin USP Related Compound A/ Levofloxacin EP Impurity B NLT 95%
- Inquiry
- 2026-04-02
-
VIP4年
- GLP Pharma Standards
- Levofloxacin EP Impurity-B / Levofloxacin Related Compound A 117707-40-1 NLT 95%
- Inquiry
- 2026-04-02
-
VIP0年
- GLP Pharma Standards
- Levofloxacin EP Impurity-B / Levofloxacin Related Compound A 117707-40-1 NLT 95%
- Inquiry
- 2026-04-02
Other Switzerland
- Address: FF-4, Limbani Complex, Nr. Gormoh Hotel, Iscon-Bopal Road, Ambli, Ahmedabad, India - 380058
INQUIRY